Using exercise endpoints in heart failure trials: design considerations

Eur Heart J. 1996 Jan;17(1):4-6. doi: 10.1093/oxfordjournals.eurheartj.a014690.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiotonic Agents / therapeutic use*
  • Exercise Test / drug effects
  • Exercise Test / statistics & numerical data*
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Randomized Controlled Trials as Topic
  • Reproducibility of Results
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Vasodilator Agents